Pharmaceutical: Acamprosate (36C77025Q0014)
Waiver type - Procurement: Nonavailability
Agency: VETERANS AFFAIRS, DEPARTMENT OF (3600) • Product Service Code (PSC) : 6505 | Last Modified: 11/08/2024
Procurement Summary
The acquisition is for the pharmaceutical Acamprosate CA 333MG EC for six (6) VA CMOP locations. The CMOPs have critically low stock and require this pharmaceutical to fulfill veteran prescriptions in support of their medical needs. The drug is used by patients in support of abstinence from alcohol in patients with alcohol dependence.
Waiver Rationale Summary
The solicitation included FAR 52.225-5 (Trade Agreements) and 52.225-6 (Trade Agreements Certificate) due to the solicitation having an estimated value that exceeded the Trade Agreements threshold, and being unrestricted (open to both large and small business concerns). However, market research found no U.S., or designated country end items. The solicitation confirmed the market research findings as no U.S.-made or designated country end products were quoted. Since only end products from a non designated country were quoted, a nonavailability determination is required per FAR 25.502(b)(3) and 25.103(b)(2).
Yes
No
Consistent with Policy
DRUGS AND BIOLOGICALS
325412 - Pharmaceutical Preparation Manufacturing
10/29/2024
36C77025Q0014
36C77025Q0014
Post-solicitation
Instant Delivery Only
Individual Waiver
VETERANS AFFAIRS, DEPARTMENT OF